In this paper, we present the computational tools and a hardware prototype for 3D face recognition. Full automation is provided through the use of advanced multistage alignment algorithms, resilience to facial expressions by employing a deformable model framework, and invariance to 3D capture devices through suitable preprocessing steps. In addition, scalability in both time and space is achieved by converting 3D facial scans into compact metadata. We present our results on the largest known, and now publicly available, face recognition grand challenge 3D facial database consisting of several thousand scans. To the best of our knowledge, this is the highest performance reported on the FRGC v2 database for the 3D modality
Background: Studies have demonstrated that the current US guidelines based on American College of Cardiology/American Heart Association (ACC/AHA) Pooled Cohort Equations Risk Calculator may underestimate risk of atherosclerotic cardiovascular disease ( CVD ) in certain high‐risk individuals, therefore missing opportunities for intensive therapy and preventing CVD events. Similarly, the guidelines may overestimate risk in low risk populations resulting in unnecessary statin therapy. We used Machine Learning ( ML ) to tackle this problem. Methods and Results: We developed a ML Risk Calculator based on Support Vector Machines ( SVM s) using a 13‐year follow up data set from MESA (the Multi‐Ethnic Study of Atherosclerosis) of 6459 participants who were atherosclerotic CVD‐free at baseline. We provided identical input to both risk calculators and compared their performance. We then used the FLEMENGHO study (the Flemish Study of Environment, Genes and Health Outcomes) to validate the model in an external cohort. ACC / AHA Risk Calculator, based on 7.5% 10‐year risk threshold, recommended statin to 46.0%. Despite this high proportion, 23.8% of the 480 “Hard CVD ” events occurred in those not recommended statin, resulting in sensitivity 0.76, specificity 0.56, and AUC 0.71. In contrast, ML Risk Calculator recommended only 11.4% to take statin, and only 14.4% of “Hard CVD ” events occurred in those not recommended statin, resulting in sensitivity 0.86, specificity 0.95, and AUC 0.92. Similar results were found for prediction of “All CVD ” events. Conclusions: The ML Risk Calculator outperformed the ACC/AHA Risk Calculator by recommending less drug therapy, yet missing fewer events. Additional studies are underway to validate the ML model in other cohorts and to explore its ability in short‐term CVD risk prediction.
10 March 2011 in IEEE Transactions on Pattern Analysis and Machine Intelligence
The uncontrolled conditions of real-world biometric applications pose a great challenge to any face recognition approach. The unconstrained acquisition of data from uncooperative subjects may result in facial scans with significant pose variations along the yaw axis. Such pose variations can cause extensive occlusions, resulting in missing data. In this paper, a novel 3D face recognition method is proposed that uses facial symmetry to handle pose variations. It employs an automatic landmark detector that estimates pose and detects occluded areas for each facial scan. Subsequently, an Annotated Face Model is registered and fitted to the scan. During fitting, facial symmetry is used to overcome the challenges of missing data. The result is a pose invariant geometry image. Unlike existing methods that require frontal scans, the proposed method performs comparisons among interpose scans using a wavelet-based biometric signature. It is suitable for real-world applications as it only requires half of the face to be visible to the sensor. The proposed method was evaluated using databases from the University of Notre Dame and the University of Houston that, to the best of our knowledge, include the most challenging pose variations publicly available. The average rank-one recognition rate of the proposed method in these databases was 83.7 percent.
1 March 2014 in Computerized Medical Imaging and Graphics
This paper describes an evaluation framework that allows a standardized and quantitative comparison of IVUS lumen and media segmentation algorithms. This framework has been introduced at the MICCAI 2011 Computing and Visualization for (Intra)Vascular Imaging (CVII) workshop, comparing the results of eight teams that participated. We describe the available data-base comprising of multi-center, multi-vendor and multi-frequency IVUS datasets, their acquisition, the creation of the reference standard and the evaluation measures. The approaches address segmentation of the lumen, the media, or both borders; semi- or fully-automatic operation; and 2-D vs. 3-D methodology. Three performance measures for quantitative analysis have been proposed. The results of the evaluation indicate that segmentation of the vessel lumen and media is possible with an accuracy that is comparable to manual annotation when semi-automatic methods are used, as well as encouraging results can be obtained also in case of fully-automatic segmentation. The analysis performed in this paper also highlights the challenges in IVUS segmentation that remains to be solved.